Works matching DE "HOFFMANN-La Roche Inc."

Results: 70

Debating Clinical Registries and Databases.

Published in:

Bio-IT World, 2006, v. 5, n. 3, p. 34

By:

Uehling, Mark D.

Publication type:

Article

De-Lovely Pharmaceuticals.

Published in:

Bio-IT World, 2004, v. 3, n. 11, p. 44

By:

Davies, Kevin

Publication type:

Article

Forecasting the Future for Pharma.

Published in:

Bio-IT World, 2004, v. 3, n. 1, p. 27

By:

Smyth, Simon

Publication type:

Article

DeCODE Scientists Decode Stroke Gene.

Published in:

Bio-IT World, 2003, v. 2, n. 11, p. 16

By:

Strattner, Tony

Publication type:

Article

Contest in prospect over interferon rights.

Published in:

Nature, 1985, p. 207, doi. 10.1038/314207a0

By:

Beardsley, Tim

Publication type:

Article

TECHNICAL EXHIBITORS.

Published in:: American Journal of Gastroenterology (Springer Nature), 1961, v. 36, n. 3, p. 376
Publication type:: Article

Drug may prevent organ rejection.

Published in:: Urology Times, 1995, v. 23, n. 9, p. 30
Publication type:: Article

Etretinate (Tegison®) Follow-up Study.

Published in:: Journal of Dermatologic Surgery & Oncology, 1987, v. 13, n. 6, p. 669
Publication type:: Article

Product Update.

Published in:

2011

By:

Bhalla, Alka

Publication type:

Product Review

Roche opts for non-exclusive rights and ends dispute.

Published in:: Chemistry & Industry, 2003, n. 15, p. 6
Publication type:: Article

EU gives DSM ok.

Published in:: Chemistry & Industry, 2003, n. 15, p. 4
Publication type:: Article

Capecitabine (Xeloda®).

Published in:

Clinical Journal of Oncology Nursing, 2001, v. 5, n. 1, p. 2

By:

Immerman, Darlene

Publication type:

Article

Roche Oncology:Targeting Cancer With Care.

Published in:: ONS News, 2004, v. 19, n. 6, p. 16
Publication type:: Article

Licences sought from PCR users in Britain.

Published in:

Nature, 1993, v. 361, n. 6410, p. 291, doi. 10.1038/361291b0

By:

Dickson, David

Publication type:

Article

Roche cuts controversial PCR fees, testing limits.

Published in:

Nature, 1992, v. 355, n. 6359, p. 379, doi. 10.1038/355379a0

By:

Anderson, C.

Publication type:

Article

Deal watch: Synta and Roche collaborate on anti-inflammatory ion channel modulators.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 184, doi. 10.1038/nrd2839
Publication type:: Article

Star role for bacteria in controlling flu pandemic?

Published in:

Nature Reviews Drug Discovery, 2005, v. 4, n. 12, p. 945, doi. 10.1038/nrd1917

By:

Bradley, David

Publication type:

Article

The licensing gamble: raising the stakes.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 2, p. 107, doi. 10.1038/nrd1310

By:

Featherstone, James;
Renfrey, Siˆn

Publication type:

Article

Roche backs Aileron's stapled peptides.

Published in:

Nature Biotechnology, 2010, v. 28, n. 10, p. 992, doi. 10.1038/nbt1010-992c

By:

Sheridan, Cormac

Publication type:

Article

PhRMA wants you!

Published in:: 2010
Publication type:: Editorial

Antisoma–Roche deal—a new kind of buyout?

Published in:

Nature Biotechnology, 2003, v. 21, n. 1, p. 3, doi. 10.1038/nbt0103-3a

By:

Mitchell, Peter

Publication type:

Article

In Brief.

Published in:

Nature Biotechnology, 2002, v. 20, n. 8, p. 763, doi. 10.1038/nbt0802-763

By:

Bouchie, Aaron;
Davidson, Sylvia;
Dorey, Emma;
Fox, Jeffrey L.;
Triendl, Robert

Publication type:

Article

Roche's Taq patent invalid.

Published in:

Nature Biotechnology, 2000, v. 18, n. 1, p. 7, doi. 10.1038/71967

By:

Niiler, Eric

Publication type:

Article

Research collaborations.

Published in:

Nature Biotechnology, 1999, v. 17, n. 9, p. 838, doi. 10.1038/12797

By:

Dorey, Emma

Publication type:

Article

Genentech relaunched with independence intact.

Published in:

Nature Biotechnology, 1999, v. 17, n. 7, p. 634, doi. 10.1038/10842

By:

Glaser, Vicki

Publication type:

Article

PATIENT EDUCATION CD-ROM AVAILABLE.

Published in:: AIDS Patient Care & STDs, 1999, v. 13, n. 7, p. 442
Publication type:: Article

Progan studies against CMV disease on hold.

Published in:: AIDS Patient Care & STDs, 1997, v. 11, n. 5, p. 375
Publication type:: Article

New gel formulation for saquinavir.

Published in:: AIDS Patient Care & STDs, 1997, v. 11, n. 5, p. 373
Publication type:: Article

Combination study of Invirase and Norvir starting.

Published in:: AIDS Patient Care & STDs, 1996, v. 10, n. 3, p. 187
Publication type:: Article

Our Thanks to Roche Dermatologics, a Division of Hoffman-La Roche Inc.

Published in:

Journal of Investigative Dermatology, 1999, v. 113, n. 4, doi. 10.1046/j.1523-1747.1999.113004521.x

By:

Hauser, C.;
Uitto, Jouni

Publication type:

Article

KEYSTONE SYMPOSIA 1991 CONFERENCES.

Published in:: 1990
Publication type:: Proceeding

The Society for Investigative Dermatology, Inc. and European Society for Dermatological Research Joint International Meeting.

Published in:: Journal of Investigative Dermatology, 1983, v. 80, n. 4, p. 302, doi. 10.1111/1523-1747.ep12534716
Publication type:: Article

Acknowledgment.

Published in:: Journal of Investigative Dermatology, 1980, v. 74, n. 1, p. 58, doi. 10.1111/1523-1747.ep12514619
Publication type:: Article

Roche and Promega back in court for Taq.

Published in:

Nature, 1999, v. 397, n. 6719, p. 460, doi. 10.1038/17169

By:

Lehrman, Sally

Publication type:

Article

Australia annuls Roche's native Taq patent.

Published in:

Nature, 1997, v. 390, n. 6658, p. 327, doi. 10.1038/36957

By:

Dickson, David

Publication type:

Article

Roche claims victory in bid for European Taq patent.

Published in:

Nature, 1996, v. 384, n. 6605, p. 100, doi. 10.1038/384100b0

By:

Dickson, David

Publication type:

Article

Roche fails to get European patent on Taq polymerase.

Published in:

Nature, 1996, v. 382, n. 6587, p. 100, doi. 10.1038/382100a0

By:

Dickson, David

Publication type:

Article

Promega, Roche clash over use of Taq in labs.

Published in:

Nature, 1995, v. 375, n. 6530, p. 348, doi. 10.1038/375348a0

By:

Lehrman, Sally;
Dickson, David

Publication type:

Article

Roche asked for more Taq patent evidence.

Published in:: Nature, 1995, v. 374, n. 6518, p. 108, doi. 10.1038/374108b0
Publication type:: Article

Roche pledges independence to new institute.

Published in:

Nature, 1995, v. 373, n. 6510, p. 94, doi. 10.1038/373094a0

By:

Macilwain, Colin

Publication type:

Article

Promega files court challenge to Roche's Taq enzyme patent.

Published in:

Nature, 1994, v. 372, n. 6508, p. 714, doi. 10.1038/372714b0

By:

Dickson, David

Publication type:

Article

Patent on PCR enzymes may re-ignite old controversy.

Published in:

Nature, 1994, v. 372, n. 6503, p. 212, doi. 10.1038/372212a0

By:

Dickson, David

Publication type:

Article

Roche loses round in interferon patent battle.

Published in:

Nature, 1994, v. 368, n. 6471, p. 486, doi. 10.1038/368486a0

By:

Swinbanks, David

Publication type:

Article

Wider Access Provided to AIDS Drugs With Actions Against HIV, CMV Infections.

Published in:

JAMA: Journal of the American Medical Association, 1990, v. 264, n. 15, p. 1926, doi. 10.1001/jama.1990.03450150024007

By:

Cotton, Paul

Publication type:

Article

PHARMACY CORNER.

Published in:: Oncology Nursing Forum, 2000, v. 27, n. 3, p. 549
Publication type:: Article

LOYALTY REBATES AFTER INTEL: TIME FOR THE EUROPEAN COURT OF JUSTICE TO OVERRULE HOFFMAN-LA ROCHE.

Published in:

Journal of Competition Law & Economics, 2015, v. 11, n. 3, p. 579, doi. 10.1093/joclec/nhv023

By:

Geradin, Damien

Publication type:

Article

Talking with Richard Aderman of Roche Laboratory Systems.

Published in:

2002

By:

Pontius, C. Anne

Publication type:

Interview

THE CORPORATE SIDESHOW.

Published in:: Business & Society Review (00453609), 1984, n. 51
Publication type:: Article

Office Help for Home Problems.

Published in:: Business & Society Review (00453609), 1983, n. 45
Publication type:: Article

Interleukin inhibitors effectively treat systemic juvenile idiopathic arthritis.

Published in:

Expert Review of Clinical Immunology, 2013, v. 9, n. 2, p. 104, doi. 10.1002/art.37759

By:

Patience, Jonny

Publication type:

Article